Ergoteles LLC Gsk PLC Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$42.05 - $47.77 $3.61 Million - $4.1 Million	85,904 New	85,904 $3.74 Million
Q1 2022 May 13, 2022	SELL	$40.23 - $47.74 $535,823 - $635,849	-13,319 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $279,936 - $326,232	7,200 Added 117.67%	13,319 $587,000
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $237,356 - $264,096	6,119 New	6,119 $234,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.